Response to brentuximab vedotin versus physician’s choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis
暂无分享，去创建一个
M. Weichenthal | R. Dummer | O. Akilov | J. Scarisbrick | P. Zinzani | D. Fisher | S. Horwitz | S. Whittaker | P. Ortiz-Romero | H. Prince | M. Onsum | P. Quaglino | R. Stadler | M. Duvic | Youn H. Kim | P. Wolter | J. Walewski | O. Bechter | J. Trotman | W. Trepicchio | L. Pinter-Brown | A. Gru | J. Sanches | H. Eradat | M. Palanca-Wessels | V. Bunn | K. Taylor | M. Little | J. Lisano | M. McNeeley | L. Brown | M. C. Palanca-Wessels